This company seems to have been delisted
Reason: Shutdown after failing to find a buyer
Last recorded trade on: February 24, 2023
Source: https://www.fiercebiotech.com/biotech/genocea-closes-shop-after-failing-find-buyer-delists-nasdaq
Reason: Shutdown after failing to find a buyer
Last recorded trade on: February 24, 2023
Source: https://www.fiercebiotech.com/biotech/genocea-closes-shop-after-failing-find-buyer-delists-nasdaq
Genocea Biosciences
GNCA
S$0.0001288
Share price
-85.71%
Change (1 day)
N/A
Change (1 year)
Categories
Earnings for Genocea Biosciences (GNCA)
Earnings in 2022 (TTM): -S$50.31 Million
According to Genocea Biosciences 's latest financial reports the company's current earnings are S$1.91 Million. In 2021 the company made an earning of -S$42.75 Million, an increase over its 2020 earnings that were of -S$56.29 Million. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Genocea Biosciences from 2013 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2022 (TTM)  | -S$50.31 Million | 17.71% |
| 2021 | -S$42.75 Million | -24.06% |
| 2020 | -S$56.29 Million | 12.23% |
| 2019 | -S$50.16 Million | 40.05% |
| 2018 | -S$35.81 Million | -50.96% |
| 2017 | -S$73.02 Million | 14.4% |
| 2016 | -S$63.83 Million | 16.69% |
| 2015 | -S$54.7 Million | 20.36% |
| 2014 | -S$45.45 Million | 69.64% |
| 2013 | -S$26.79 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Agenus
AGEN | -S$0.13 Billion | 153.37% | 🇺🇸 USA |
 Novavax NVAX | S$0.65 B | -1,471.85% | 🇺🇸 USA |
 Merck MRK | S$27.61 B | -57,775.24% | 🇺🇸 USA |
 iBio IBIO | -S$20.9 Million | -56.36% | 🇺🇸 USA |
 Pfizer PFE | S$13.31 B | -27,905.11% | 🇺🇸 USA |